Research Administration Operations Update

Tuesday, May 18, 2021 02:00pm, EDT

Partnerships

Stories

Abstract illustration of globe with network connections

Leading experts at Rutgers and Tel Aviv Universities hosted a symposium centered on the coronavirus pandemic and the research, response and lessons learned through the COVID-19 outbreak in the sister states of New Jersey and Israel. The virtual event was the first in a monthly series of joint scientific symposia and a broader research-based collaboration between the two universities.

Rutgers Shield Logo

Rutgers University signs two agreements with Santhera Pharmaceuticals to advance pioneering research for the treatment of congenital muscular dystrophy. The agreements complement ongoing research of Peter Yurchenco, professor at Rutgers Robert Wood Johnson Medical School and a pioneer in a novel gene therapy approach for the treatment of LAMA2-deficient congenital muscular dystrophy.